Publications

Export 746 results:
Auteur Title Type [ Année(Asc)]
Filtres: First Letter Of Last Name is H  [Enlever les filtres]
2019
Orrico-Sanchez A, Chausset-Boissarie L, de Sousa RAlves, Coutens B, Amin SRezai, Vialou V, Louis F, Hessani A, Dansette PM, Zornoza T et al..  2019.  Antidepressant efficacy of a selective organic cation transporter blocker in a mouse model of depression.. Mol Psychiatry.
MJ Fleury, Fortin M, Rochette L, Grenier G, Huỳnh C, Pelletier É, Vasiliadis HM.  2019.  Assessing quality indicators related to mental health emergency room utilization.. BMC Emerg Med. 19(1):8.
Takado Y, Sato N, Kanbe Y, Tomiyasu M, Xin L, Near J, Yoshikawa K, Sahara N, Higashi T, Suhara T et al..  2019.  Association between Brain and Plasma Glutamine Levels in Healthy Young Subjects Investigated by MRS and LC/MS.. Nutrients. 11(7)
Takado Y, Sato N, Kanbe Y, Tomiyasu M, Xin L, Near J, Yoshikawa K, Sahara N, Higashi T, Suhara T et al..  2019.  Association between Brain and Plasma Glutamine Levels in Healthy Young Subjects Investigated by MRS and LC/MS.. Nutrients. 11(7)
Yusuf A, Peltekova I, Savion-Lemieux T, Frei J, Bruno R, Joober R, Howe J, Scherer SW, Elsabbagh M.  2019.  Association between distress and knowledge among parents of autistic children.. PLoS One. 14(9):e0223119.
Carter SF, Herholz K, Rosa-Neto P, Pellerin L, Nordberg A, Zimmer ER.  2019.  Astrocyte Biomarkers in Alzheimer's Disease.. Trends Mol Med.
Xiong W, Cao X, Zeng Y, Qin X, Zhu M, Ren J, Wu Z, Huang Q, Zhang Y, Wang M et al..  2019.  Astrocytic Epoxyeicosatrienoic Acid Signaling in the Medial Prefrontal Cortex Modulates Depressive-like Behaviors.. J Neurosci. 39(23):4606-4623.
Liebsch F, Kulic L, Teunissen C, Shobo A, Ulku I, Engelschalt V, Hancock MA, van der Flier WM, Kunach P, Rosa-Neto P et al..  2019.  Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer's disease progression.. Nat Commun. 10(1):2240.
Liebsch F, Kulic L, Teunissen C, Shobo A, Ulku I, Engelschalt V, Hancock MA, van der Flier WM, Kunach P, Rosa-Neto P et al..  2019.  Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer's disease progression.. Nat Commun. 10(1):2240.
Ehrlich AT, Semache M, Gross F, Da Fonte DF, Runtz L, Colley C, Mezni A, Le Gouill C, Lukasheva V, Hogue M et al..  2019.  Biased Signaling of the Mu Opioid Receptor Revealed in Native Neurons.. iScience. 14:47-57.
Aristizabal MJ, Anreiter I, Halldorsdottir T, Odgers CL, McDade TW, Goldenberg A, Mostafavi S, Kobor MS, Binder EB, Sokolowski MB et al..  2019.  Biological embedding of experience: A primer on epigenetics.. Proc Natl Acad Sci U S A.
Zhang T-Y, Shahrokh D, Hellstrom IC, Wen X, Diorio J, Breuillaud L, Caldji C, Meaney MJ.  2019.  Brain-Derived Neurotrophic Factor in the Nucleus Accumbens Mediates Individual Differences in Behavioral Responses to a Natural, Social Reward.. Mol Neurobiol.
Freitas R, Santos BDos, Altamura C, Bernasconi C, Corral R, Evans J, Malla A, Krebs M-O, Nordstroem A-L, Zink M et al..  2019.  Can the Positive and Negative Syndrome scale (PANSS) differentiate treatment-resistant from non-treatment-resistant schizophrenia? A factor analytic investigation based on data from the Pattern cohort study. Psychiatry Res. 276:210-217.
Chertkow H, Borrie M, Whitehead V, Black SE, Feldman HH, Gauthier S, Hogan DB, Masellis M, McGilton K, Rockwood K et al..  2019.  The Comprehensive Assessment of Neurodegeneration and Dementia: Canadian Cohort Study.. Can J Neurol Sci. 46(5):499-511.
Chertkow H, Borrie M, Whitehead V, Black SE, Feldman HH, Gauthier S, Hogan DB, Masellis M, McGilton K, Rockwood K et al..  2019.  The Comprehensive Assessment of Neurodegeneration and Dementia: Canadian Cohort Study.. Can J Neurol Sci. 46(5):499-511.
Schelter BO, Shiells H, Baddeley TC, Rubino CM, Ganesan H, Hammel J, Vuksanovic V, Staff RT, Murray AD, Bracoud L et al..  2019.  Concentration-Dependent Activity of Hydromethylthionine on Cognitive Decline and Brain Atrophy in Mild to Moderate Alzheimer's Disease.. J Alzheimers Dis. 72(3):931-946.
Schelter BO, Shiells H, Baddeley TC, Rubino CM, Ganesan H, Hammel J, Vuksanovic V, Staff RT, Murray AD, Bracoud L et al..  2019.  Concentration-Dependent Activity of Hydromethylthionine on Cognitive Decline and Brain Atrophy in Mild to Moderate Alzheimer's Disease.. J Alzheimers Dis. 72(3):931-946.
Belleville S, LeBlanc AC, Kergoat M-J, Calon F, Gaudreau P, Hébert SS, Hudon C, Leclerc N, Mechawar N, Duchesne S et al..  2019.  The Consortium for the early identification of Alzheimer's disease-Quebec (CIMA-Q).. Alzheimers Dement (Amst). 11:787-796.
Belleville S, LeBlanc AC, Kergoat M-J, Calon F, Gaudreau P, Hébert SS, Hudon C, Leclerc N, Mechawar N, Duchesne S et al..  2019.  The Consortium for the early identification of Alzheimer's disease-Quebec (CIMA-Q).. Alzheimers Dement (Amst). 11:787-796.
Papadopoulou A, Gaetano L, Pfister A, Altermatt A, Tsagkas C, Morency F, Brandt AU, Hardmeier M, M Chakravarty M, Descoteaux M et al..  2019.  Damage of the lateral geniculate nucleus in MS: Assessing the missing node of the visual pathway.. Neurology. 92(19):e2240-e2249.
Cuesta S, Restrepo-Lozano JMaria, Popescu C, He S, Reynolds LM, Israel S, Hernandez G, Rais R, Slusher BS, Flores C.  2019.  DCC-related developmental effects of abused- versus therapeutic-like amphetamine doses in adolescence.. Addict Biol. :e12791.

Pages